Explore approved biosimilar medicines
| # | Medicine | Status | Active Substance | Therapeutic Area | Developer | Published Date |
|---|---|---|---|---|---|---|
| 1 | Zarzio | Authorised | filgrastim | Hematopoietic Stem Cell Transplantation;Cancer | Sandoz GmbH | 24-05-2018 |
| 2 | Idacio | Authorised | adalimumab | Arthritis, Rheumatoid;Arthritis, Psoriatic;Psoriasis;Spondylitis, Ankylosing;Uveitis;Hidradenitis Suppurativa;Colitis, Ulcerative;Crohn Disease;Arthritis, Juvenile Rheumatoid | Fresenius Kabi Deutschland GmbH | 17-04-2019 |
| 3 | Zandoriah | Authorised | teriparatide | Osteoporosis;Osteoporosis, Postmenopausal | CinnaGen Co Unipessoal LDA | 27-02-2026 |
| 4 | Ranluspec | Authorised | ranibizumab | Wet Macular Degeneration;Macular Edema;Diabetic Retinopathy;Diabetes Complications;Retinal Vein Occlusion;Choroidal Neovascularization | Lupin Europe GmbH | 12-12-2025 |
| 5 | Fubelv | Authorised | etanercept | Arthritis, Rheumatoid;Arthritis, Juvenile;Arthritis, Psoriatic;Axial Spondyloarthritis;Non-Radiographic Axial Spondyloarthritis;Spondylitis, Ankylosing;Psoriasis | Biosimilar Collaborations Ireland Limited | 27-02-2026 |
| 6 | Poherdy | Authorised | pertuzumab | Breast Neoplasms | Organon N.V. | 27-02-2026 |
| 7 | Yesintek | Authorised | ustekinumab | Psoriasis;Arthritis, Psoriatic;Crohn Disease | Biosimilar Collaborations Ireland Limited | 13-12-2024 |
| 8 | Otulfi | Authorised | ustekinumab | Crohn Disease;Colitis, Ulcerative | Fresenius Kabi Deutschland GmbH | 26-07-2024 |
| 9 | Jubereq | Authorised | denosumab | Neoplasms, Bone Tissue;Giant Cell Tumor of Bone | Accord Healthcare S.L.U. | 28-03-2025 |
| 10 | Osvyrti | Authorised | Bone Resorption;Osteoporosis;Osteoporosis, Postmenopausal | Accord Healthcare S.L.U. | 28-03-2025 |
Ready to transform your strategic intelligence? Let's talk
Get latest pharmaceutical insights, blogs, and strategic updates directly in your inbox.